Unusual [4+2]-Cycloaddition
Reaction between Electron-Poor 1,2-Diaza-1,3-dienes and
Electron-Poor Alkenes: Useful Entry to Novel Tetrahydropyridazines

Maurizio D’Auria; Rocco Racioppi; Orazio A. Attanasi; Fabio Mantellini

doi:10.1055/s-0029-1219834

LETTER

Unusual [4+2]-Cycloaddition Reaction between Electron-Poor 1,2-Diaza-1,3-dienes and Electron-Poor Alkenes: Useful Entry to Novel Tetrahydropyridazines

Maurizio D’Auria*^a, Rocco Racioppi^a, Orazio A. Attanasi^b, Fabio Mantellini^b
^a Dipartimento di Chimica, Università della Basilicata, Via N. Sauro 85, 85100 Potenza, Italy
Fax: +39(0971)202223; e-Mail: maurizio.dauria@unibas.it;
^b Istituto di Chimica Organica della Facoltà di Scienze e Tecnologie, Università degli Studi di Urbino ‘Carlo Bo’, Via I. Maggetti 24, 61029 Urbino, Italy

Abstract

Alle Artikel dieser Rubrik

Abstract

1,2-Diaza-1,3-dienes react with electron-poor alkenes to give the corresponding tetrahydropyridazines with high regio- and stereoselectivity. Both regio- and stereoselectivity can be explained considering the interaction between the LUMO of the 1,2-diaza-1,3-diene and HOMO-1 of the alkene.

Key words

1,2-diaza-1,3-dienes - electron-poor alkenes - [4+2] cycloaddition - regioselectivity - stereoselectivity - DFT calculations

Volltext

Referenzen

References and Notes

<A NAME="RD05110ST-1A">1a</A> Attanasi OA. De Crescentini L. Filippone P. Mantellini F. Santeusanio S. ARKIVOC 2002, (xi): 274

<A NAME="RD05110ST-1B">1b</A> Attanasi OA. De Crescentini L. Favi G. Filippone P. Mantellini F. Perrulli FR. Santeusanio S. Eur. J. Org. Chem. 2009, 3109

<A NAME="RD05110ST-2A">2a</A> Attanasi OA. Caglioti L. Org. Prep. Proced. Int. 1986, 18: 299

<A NAME="RD05110ST-2B">2b</A> Schantl JG. In Houben-Weyl Vol E15: Kropf H. Schaumann E. Thieme; Stuttgart: 1990. p.909-1100

<A NAME="RD05110ST-3A">3a</A> Zelenin KN. Matveeva ZM. Ermolaeva LYu. Zh. Org. Khim. 1970, 6: 723

<A NAME="RD05110ST-3B">3b</A> Zelenin KN. Bezhan IP. Matveeva ZM. Khim. Geterosikl. Soedin. 1972, 579

<A NAME="RD05110ST-3C">3c</A> Zelenin KN. Nikitin VA. Anodina NM. Khim. Geterosikl. Soedin. 1973, 124

<A NAME="RD05110ST-4A">4a</A> Boger DL. Tetrahedron 1983, 39: 2869

<A NAME="RD05110ST-4B">4b</A> Gilchrist TL. Stevens JA. Parton B. J. Chem. Soc., Perkin Trans. 1 1985, 1741

<A NAME="RD05110ST-4C">4c</A> Boger DL. Chem. Rev. 1986, 86: 781

<A NAME="RD05110ST-4D">4d</A> Boger DL. Weinreb SM. Hetero Diels-Alder Methodology in Organic Synthesis Academic Press; San Diego: 1987.

<A NAME="RD05110ST-4E">4e</A> Fringuelli F. Taticchi A. Dienes in the Diels-Alder Reaction Wiley Interscience; New York: 1990.

<A NAME="RD05110ST-4F">4f</A> South MS. Jakuboski TL. Westmeyer MD. Dukesherer DR. J. Org. Chem. 1996, 61: 8921

<A NAME="RD05110ST-4G">4g</A> South MS. J. Heterocycl. Chem. 1999, 36: 301

<A NAME="RD05110ST-4H">4h</A> Attanasi OA. De Crescentini L. Filippone P. Fringuelli F. Mantellini F. Matteucci M. Piermatti O. Pizzo F. Helv. Chim. Acta 2001, 84: 513

<A NAME="RD05110ST-4I">4i</A> Fringuelli F. Taticchi A. The Diels-Alder Reaction: Selected Practical Methods John Wiley and Sons; New York: 2002.

<A NAME="RD05110ST-5">5</A> D’Auria M. Racioppi R. Viggiani L. Zanirato P. Eur. J. Org. Chem. 2009, 932

Synthesis of Compound 3a
DD 1a (370 mg; 2 mmol) was added under vigorous stirring to a solution of methyl crotonate (2a, 2.0 g; 20 mmol) in MeCN (40 mL). The reaction was heated to reflux for 48 h, and then the solvent was evaporated under reduced pressure to afford the crude mixture, which was chromatographed on silica gel (EtOAc-PE, 1:1 to 7:3) to give pure THP 3a (370 mg, 65% yield).

Compound 3a: ^¹H NMR (500 MHz, CDCl₃): δ = 6.40-6.00 (2 H, br s), 5.00 (1 H, q, J = 6.8 Hz), 4.17 (2 H, m), 3.65 (3 H, s), 3.51 (1 H, s), 3.42 (1 H, s), 2.14 (3 H, s), 1.26 (3 H, t, J = 7.2 Hz), 1.04 (3 H, d, J = 6.8 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 169.49, 167.29, 153.79, 139.07, 59.58, 50.46, 41.53, 40.98, 38.56, 22.02, 14.42, 11.61 ppm. MS: m/z (%) 285 (23), 239 (80), 226 (7), 211 (10), 197 (10), 196 (38), 184 (7), 183 (28), 181 (13), 169 (18), 168 (10), 167 (48), 155 (8), 154 (23), 153 (100), 141 (13), 139 (8), 137 (27), 128 (22), 109 (32), 96 (27), 95 (35). Anal. Calcd (%) for C₁₂H₁₉N₃O₅: C, 50.52; H, 6.71; N, 14.73. Found: C, 50.55; H, 6.68; N, 14.75.
Compound 3b: ^¹H NMR (500 MHz, CDCl₃): δ = 6.40-5.80 (2 H, br s), 5.01 (1 H, q, J = 6.8 Hz), 3.70 (3 H, s), 3.64 (3 H, s), 3.57 (1 H, s), 3.41 (1 H, s), 2.56 (1 H, dq, J ₁ = J ₂ = 7.6 Hz), 2.37 (1 H, dq, J ₁ = J ₂ = 7.6 Hz), 1.11 (3 H, t, J = 7.6 Hz), 1.03 (3 H, d, J = 6.8 Hz) ppm.^¹³C NMR (125 MHz, CDCl₃): δ = 171.92, 170.63, 156.55, 145.15, 52.98, 52.89, 44,40, 43.53, 39.55, 30.50, 17.12, 10.68 ppm. MS: m/z (%) = 285 (19), 254 (17), 253 (52), 226 (10), 211 (11), 210 (25), 183 (29), 181 (17), 168 (18), 167 (100), 151 (13), 142 (10), 128 (18), 123 (16), 113 (10), 110 (11), 109 (21), 96 (11). Anal. Calcd (%) for C₁₁H₁₇N₃O₅: C, 48.70; H, 6.32; N, 15.49. Found: C, 48.73; H, 6.36; N, 15.46.
Compound 3c: ^¹H NMR (500 MHz, CDCl₃): δ = 8.44 (1 H, s), 7.41 (2 H, m), 7.20 (2 H, m), 6.94 (1 H, m), 5.07 (1 H, q, J = 7.5 Hz), 3.70 (3 H, s), 3.62 (3 H, s), 3.52 (1 H, s), 3.44 (1 H, s), 2.19 (3 H, s), 1.05 (3 H, d, J = 7.5 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 172.02, 170.37, 152.19, 141.57, 138.62, 129.11, 123.18, 119.34, 53.16, 53.04, 44.26, 43.67, 41.16, 24.68, 17.04 ppm. MS: m/z (%) = 348 (8), 347 (44), 316 (9), 315 (40), 197 (21), 196 (70), 170 (8), 169 (59), 167 (13), 155 (14), 154 (24), 153 (100), 138 (18), 129 (38), 109 (26), 96 (24), 95 (28), 77 (12). Anal. Calcd (%) for C₁₇H₂₁N₃O₅: C, 58.78; H, 6.09; N, 12.10. Found: C, 58.72; H, 6.12; N, 12.05.
Compound 3d: ^¹H NMR (500 MHz, CDCl₃): δ = 6.50-6.00 (2 H, br s), 4.71 (1 H, d, J = 1.0 Hz), 4.19 (2 H, m), 3.74 (3 H, s), 3.67 (1 H, s), 3.45 (1 H, dd, J ₁ = J ₂ = 1.0 Hz), 2.75 (1 H, d, J = 1.0 Hz), 2.12 (3 H, s), 1.29 (3 H, t, J = 7.0 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 170.87, 168.54, 156.71, 139.75, 62.06, 52.50, 43.88, 39.26, 37.16, 23.53, 14.29 ppm. MS: m/z (%) = 271 (10), 226 (8), 225 (36), 212 (8), 183 (9), 182 (24), 170 (9), 169 (92), 167 (9), 155 (14), 154 (16), 153 (28), 141 (16), 140 (8), 139 (45), 128 (30), 123 (23), 114 (11), 97 (7), 96 (32), 95 (100), 82 (28), 68 (10), 67 (8), 59 (8), 55 (24), 54 (12), 53 (9), 44 (26). Anal. Calcd (%) for C₁₁H₁₇N₃O₅: C, 48.70; H, 6.32; N, 15.49. Found: C, 48.65; H, 6.35; N, 15.52.
Compound 3e: ^¹H NMR (500 MHz, CDCl₃): δ = 6.20-5.10 (2 H, br s), 4.10 (2 H, q, J = 7.0 Hz), 3.63 (3 H, s), 3.10 (1 H, dd, J ₁ = 12.0 Hz, J ₂ = 5.6 Hz), 2.31 (1 H, s), 1.95 (1 H, dd, J ₁ = 12.0 Hz, J ₂ = 5.6 Hz), 1.91 (3 H, s), 1.39 (3 H, s), 1.22 (3 H, t, J = 7.0 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 173.26, 170.92, 156.40, 140.74, 61.90, 60.47, 56.82, 56.52, 40.26, 32.43, 20.36, 14.25 ppm. MS: m/z (%) = 285 (4), 242 (6), 184 (12), 183 (100), 142 (12), 109 (28), 96 (10). Anal. Calcd (%) for C₁₂H₁₉N₃O₅: C, 50.52; H, 6.71; N, 14.73. Found: C, 50.55; H, 6.68; N, 14.77.
Compound 3f: ^¹H NMR (500 MHz, CDCl₃): δ = 9.40 (1 H, s), 7.07 (1 H, dq, J ₁ = 14.0 Hz, J ₂ = 7.0 Hz), 6.20-6.00 (1 H, br s), 5.91 (1 H, dd, J ₁ = J ₂ = 14.0 Hz), 5.7 (1 H, br s), 5.57 (1 H, d, J = 14.0 Hz), 4.21 (2 H, q, J = 7.0 Hz), 1.94 (3 H, s), 1.89 (3 H, d, J = 7.0 Hz), 1.26 (3 H, t, J = 7.0 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 176.00, 167.35, 165.29, 158.80, 147.39, 143.35, 121.55, 62.21, 18.40, 14.33, 13.00 ppm. MS: m/z (%) = 255 (29), 227 (12), 226 (100), 209 (50), 184 (10), 183 (67), 181 (10), 167 (27), 166 (30), 151 (47), 142 (20), 139 (30), 137 (26), 125 (10), 124 (20), 123 (26), 111 (32), 110 (10), 109 (23), 98 (22), 97 (13), 96 (33), 95 (57), 94 (11), 83 (24), 70 (14), 69 (72), 68 (13). Anal. Calcd (%) for C₁₁H₁₇N₃O₄: C, 51.76; H, 6.71; N, 16.46. Found: C, 51.80; H, 6.65; N, 16.42.
Compounds 3g and 3h: ^¹H NMR (500 MHz, CDCl₃): δ = 9.11 (s, 1 H), 7.15 (3 H, m), 7.01 (2 H, m), 6.60-6.10 (0.33 H, br s), 6.07 (0.66 H, s), 5.60-5.00 (0.66 H, br s), 4.91 (0.33 H, s), 4.05 (2 H, m), 3.82 (0.66 H, s), 3.67 (1.98 H, s), 3.64 (0.33 H, s), 3.58 (0.99 H, s), 3.38 (0.66 H, s), 3.09 (0.33 H, s), 2.08 (1.98 H, s), 2.05 (0.99 H, s), 1.13 (3 H, t, J = 7.0 Hz) ppm. ^¹³C NMR (125 MHz, CDCl₃): δ = 171.57, 170.36, 169.54, 168.38, 157.08, 156.58, 142.70, 141.43, 140.87, 137.23, 129.22, 128.53, 127.82, 127.72, 126.97, 126.18, 62.16, 61.57, 53.65, 53.17, 46.22, 44.07, 40.85, 38.67, 24.78, 24.20, 14.16, 13.72. MS (3g): m/z (%) = 347 (36), 302 (21), 301 (100), 226 (17), 258 (13), 243 (20), 242 (14), 231 (30), 230 (28), 229 (73), 217 (18), 216 (10), 215 (38), 202 (24), 200(29), 199 (43), 190 (21), 189 (35), 188 (13), 172 (16), 171 (70), 167 (13), 159 (13), 158 (47), 157 (13), 156 (16), 155 (17), 154 (32), 153 (26), 146 (19), 143 (10), 142 (12), 141 (17), 139 (10), 131 (38), 130 (42), 129 (12), 128 (48), 127 (10), 115 (23), 113 (11), 106 (20), 105 (19), 104 (73), 103 (26), 96 (27), 95 (36), 91 (14), 78 (10), 77 (39), 68 (12). MS (3h): m/z (%) = 347 (13), 304 (11), 288 (38), 246 (16), 245 (100), 204 (23), 199 (10), 172 (15), 171 (61), 158 (23), 131 (18), 130 (20), 103 (15), 95 (19). Anal. Calcd (%) for C₁₇H₂₁N₃O₅: C, 58.78; H, 6.09; N, 12.10. Found: C, 58.70; H, 6.15; N, 12.16.

<A NAME="RD05110ST-8">8</A> Frisch MJ. Trucks GW. Schlegel HB. Scuseria GE. Robb MA. Cheeseman JR. Montgomery JA. Vreven T. Kudin KN. Burant JC. Millam JM. Iyengar SS. Tomasi J. Barone V. Mennucci B. Cossi M. Scalmani G. Rega N. Petersson GA. Nakatsuji H. Hada M. Ehara M. Toyota K. Fukuda R. Hasegawa J. Ishida M. Nakajima T. Honda Y. Kitao O. Nakai H. Klene M. Li X. Knox JE. Hratchian HP. Cross JB. Adamo C. Jaramillo J. Gomperts R. Stratmann RE. Yazyev O. Austin AJ. Cammi R. Pomelli C. Ochterski JW. Ayala PY. Morokuma K. Voth GA. Salvador P. Dannenberg JJ. Zakrzewski VG. Dapprich S. Daniels AD. Strain MC. Farkas O. Malick DK. Rabuck AD. Raghavachari K. Foresman JB. Ortiz JV. Cui Q. Baboul AG. Clifford S. Cioslowski J. Stefanov BB. Liu G. Liashenko A. Piskorz P. Komaromi I. Martin RL. Fox DJ. Keith T. Al-Laham MA. Peng CY. Nanayakkara A. Challacombe M. Gill PMW. Johnson B. Chen W. Wong MW. Gonzalez C. Pople JA. Gaussian 03, Revision A.1 Gaussian Inc.; Pittsburgh: 2003.